Shire will initiate two Phase IV clinical trials to compare Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) to Concerta� (methylphenidate HCl) Extended-Release...
Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that an independent Data Monitoring Committee (DMC) has recommended continuing the pivotal Phase III RAISE trial evaluating intravenous (IV) ganaxolone for the treatment of refractory status epilepticus (RSE) following an interim analysis
Novartis,, announced that the FDA has approved an intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA).
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the FDA has approved Uptravi (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy.
Avenue Therapeutics, Inc. a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, announced that the FDA was still reviewing its New Drug Application (“NDA”) for IV tramadol and had not provided a decision regarding the NDA.
Recro Pharma, Inc. announced it has received a second Complete Response Letter (CRL) from the FDA Office of Drug Evaluation...
Pfizer Inc. and Astellas Pharma Inc. announced the Phase IV PLATO study , evaluating the efficacy and safety of continued...
Recro Pharma, Inc. announced the publication of previously reported Phase II clinical data for intravenous (IV) meloxicam for the treatment...
The FDA has approved Noxafil (posaconazole) injection (18 mg/ mL), from Merck, a new formulation of the Fungal Infection treatment...
Cempra, Inc. , a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of...